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Background: Understanding the networks of selective proteolysis that regulate
complex biological systems requires an appreciation of the molecular
mechanisms used to maintain substrate specificity. Human plasmin, a serine
protease that promotes the dissolution of blood clots and is essential in
maintaining normal hemostasis, is usually described as having broad substrate
specificity. Recent evidence that plasmin also plays a key role in a variety of
other important biological and pathological processes, however, has suggested
that this description might need to be re-evaluated.
Results: We used substrate phage display to elucidate optimal subsite
occupancy for substrates of plasmin. We identified a peptide substrate that is
cleaved 710,000-fold more efficiently by plasmin than a peptide containing the
activation sequence of plasminogen. Plasmin achieves this unexpected, large
differential activity even though both target sequences possess an arginine
residue in the P1 position. We also demonstrate that proteolysis by plasmin can
be targeted to an engineered protein substrate and that introduction of
substrate sequences identified by phage display into plasminogen increases
plasmin-mediated cleavage of the mutant 2000-fold. 
Conclusions: The specificity of plasmin is more tightly controlled than previously
recognized; interactions with substrates at all subsites between S4 and S2′
contribute to catalysis. Furthermore, in contrast to most enzymes that exhibit
positive selectivity for substrate, the evolution of substrate specificity by plasmin has
apparently been dominated by a strong negative selection against development
of autoactivation activity. This ‘negative selectivity’ avoids short-circuiting
regulation of the fibrinolytic system and other important biological processes, and
might be an important general mechanism for controlling protease cascades.
Introduction
The use of selective proteolysis to modulate protein
activity has been a recurring theme during the evolution
of a variety of complex biological systems such as fibrinol-
ysis, blood coagulation, complement activation and
embryonic development. To achieve this regulation,
which requires stringent control of proteolysis to avoid
indiscriminate, general destruction of proteins, specific
proteases have evolved several distinct mechanisms to
promote efficient cleavage of target proteases while
leaving other proteins intact [1–5]. An important first step
towards understanding the biochemistry, evolution and
regulation of many complex biological processes, there-
fore, is identification of the mechanism(s) by which spe-
cific proteolysis is accomplished. Detailed knowledge of
the molecular basis of these mechanisms can, in turn,
provide new insights into how structure regulates func-
tion during a particular biological process and how muta-
tion of proteins participating in this process can produce
pathological consequences. 
The endogenous, human fibrinolytic pathway promotes
the dissolution of blood clots and therefore serves as a crit-
ical counterbalance in vivo to the blood coagulation
cascade. Initiation of this pathway is mediated by two
closely related serine proteases, tissue-type plasminogen
activator (t-PA) and urokinase-type plasminogen activator
(u-PA), which cleave the circulating zymogen plasmino-
gen to produce the mature protease plasmin (Figure 1).
Plasmin then directly catalyzes clot dissolution by effi-
ciently degrading the fibrin meshwork of thrombi. Appre-
ciation that thrombosis is the focal event in the initiation
of acute myocardial infarction, the major cause of morbid-
ity and mortality in many countries, sparked great interest
in plasmin and the endogenous fibrinolytic cascade. In
fact, administration of plasminogen activators to convert
endogenous plasminogen into plasmin has now become
the standard of care for heart-attack patients.  
The human plasminogen activators t-PA and u-PA cleave
plasminogen efficiently but hydrolyze other substrates
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poorly [6,7]. These proteases, therefore, are highly specific
enzymes in the traditional sense — they have evolved
positive selectivity, which enables them to process one
substrate while leaving substrates with similar chemical
properties intact. Plasmin, by contrast, has been thought
to be a relatively nonselective enzyme, like trypsin.
Plasmin cleaves fibrin efficiently at multiple sites [8], and
plasmin’s catalytic activity is ultimately controlled by
binding to the serpin α2-antiplasmin [9]. 
Recent studies indicate that plasmin plays a key role in a
variety of biological processes in addition to normal hemo-
stasis. Mice deficient in plasmin(ogen), exhibit not only
extensive thrombosis [10,11] but also severe and general-
ized defects in wound-healing and tissue repair [12],
defects in smooth muscle cell migration and neointima for-
mation following vascular injury [13], and defective recruit-
ment of monocytes during an inflammatory response [14].
Furthermore, plasminogen deficiency appears to cause lig-
neous conjunctivitis in both mice [15] and humans [16,17]
and accelerate the development of vessel-wall disease in
mice predisposed to atherosclerosis [18]. Host plasminogen
has also been shown to play an important role in the life
cycle of Borrelia burgdorferi, the causative agent of Lyme
disease [19]. Finally, strong evidence has been presented
recently that plasmin mediates experimental neuronal
degeneration by acting on substrates other than fibrin [20].
Additional insights into the molecular mechanisms that
contribute to the substrate specificity of plasmin, therefore,
would be expected to increase understanding of all of
these important biological and pathological processes.
In this study, we combine substrate phage display [21,22]
with detailed kinetic analysis of the cleavage of peptides
and engineered protein substrates to elucidate the rela-
tionship between the substrate specificity of plasmin and
its biological function. We find that non-S1 subsites make
a surprisingly large contribution to the substrate selectivity
of plasmin; optimal non-S1 subsite occupancy can produce
a 710,000-fold increase in the efficiency of substrate 
catalysis by plasmin. In addition, our findings demonstrate
that, in contrast to the evolution of stringent positive
selectivity for substrate by t-PA and u-PA, the evolution of
plasmin has been dominated by a strong negative selec-
tion against the development of autoactivation activity
(i.e. activation of plasminogen by plasmin), an activity that
would short-circuit the regulation of fibrinolysis and other
key biological processes. 
Results and discussion
Construction and screening of substrate phage libraries for
cleavage by plasmin
A polyvalent fd phage library that displayed random hexa-
peptide sequences and contained 2 × 108 independent
recombinants was prepared [22]. Each member of this
library displayed an amino-terminal extension from phage
coat protein III (pIII) that contained a randomized region of
six amino acids, a six-residue linker sequence (SSGGSG,
using single-letter amino acid code), and the epitopes for
monocloncal antibody (mAb) 179 and mAb 3-E7. Because
plasmin did not digest the pIII sequence, the antibody epi-
topes or the flexible linker sequence, the loss of antibody
epitopes from the phage surface upon incubation with
plasmin required cleavage of the randomized peptide insert.
Thus, incubation of the library with plasmin, followed by
removal of phage retaining the antibody epitopes; accom-
plished a large enrichment of phage clones whose random-
ized hexamer sequence could be cleaved by plasmin. 
Identification of a consensus sequence for hydrolysis of
substrate phage
Following five rounds of selection to enrich and amplify
phage which display sequences that are readily cleaved by
plasmin, 111 phage clones were identified as plasmin sub-
strates. DNA sequencing of these clones revealed the pres-
ence of 69 distinct hexamer sequences among the selected
phage (Table 1). As expected from the trypsin-like primary
specificity of plasmin, each hexamer contained at least one
basic residue. Out of the 69 distinct, randomized hexamers
present in the selected substrate phage 15 contained a
single basic residue, and, in striking contrast to the other
two human fibrinolytic serine proteases, t-PA and u-PA,
plasmin did not demonstrate a strong preference for argi-
nine versus lysine. In eight of these 15 hexamers, the
single basic residue was arginine, whereas the remaining
seven sequences contained lysine. Examination of these 15
hexamers also indicated that plasmin exhibits a strong pref-
erence for aromatic residues at the P2 position of sub-
strates. Eleven of the 15 substrate hexamers contained
phenylalanine, tyrosine or tryptophan at the P2 position. 
This preference for large P2 residues is in striking contrast
to the specificity of t-PA and u-PA, which strongly prefer
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Figure 1
Control of fibrinolysis.
The fibrinolytic cascade
Plasminogen (Plg)
Plasmin (Plm)
a 2-Antiplasmin
Tissue plasminogen activator (t-PA)
Urokinase plasminogen activator
(u-PA)
Plasminogen
activator
inhibitor 1 and 2
(PAI 1 and 2)
Fibrin Fibrin degradation
products (clot lysis)
Chemistry & Biology
glycine or alanine at the P2 position. On the basis of the 15
substrate hexamers that contained a single basic residue,
and therefore did not present the theoretical possibility of
more than one potential cleavage site, a preliminary consen-
sus sequence for optimal subsite occupancy for substrates of
plasmin, from positions P3–P1′ emerges as X1(Y/F)(R/K)X2,
where X1 and X2 can be several different amino acids but
are most often valine and serine, respectively. The prefer-
ences of plasmin at the P3 and P1′ subsites are clearly less
stringent than those at the P1 and P2 positions. 
On the basis of analysis of selected sequences that con-
tained a single basic residue, we aligned and analyzed all
69 randomized hexamer regions present in the selected
substrate phage clones. The predicted P1 residue was argi-
nine in 40 of the substrate sequences and lysine in the
remaining 29. 46% of the selected substrate phage con-
tained an aromatic residue at the P2 position, with tyrosine
present at this position in 20% of the phage clones, pheny-
lananine in 17% and tryptophan in 9% of the sequences.
The P1′ residue of 30% of the selected hexamer
sequences was serine, whereas glycine (16 clones) and
valine (11 clones) were the most common occupants of the
P3 position of the substrate phage. In 11 of 16 clones con-
taining glycine at P3, however, the glycine residue was
contributed by fixed flanking sequences in the substrate
phage rather than the randomized hexamer region.
On the basis of our experience with several related pro-
teases [6,7,23], the catalytic efficiency of plasmin toward
the most and least labile of the selected substrate
sequences would be expected to vary by at least three
orders of magnitude. Acquisition of the clearest and most
accurate information regarding optimal subsite occupancy
for substrates of plasmin, therefore, requires identification
and examination of the most labile substrate sequences
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Table 1
Alignment of the amino acid sequences of the randomized regions of phage clones selected by substrate phage display.
Clone Clone
# P6 P5 P4 P3 P2 P1 P1′ P2′ P3′ P4′ # P5 P4 P3 P2 P1 P1′ P2′ P3′ P4′ P5′ P6′ P7′
1 L V W R S H 36 F V K R A R
2 V F R S T G 37 K I G R N T
3 V F R S T F 38 V L R K R A
4 N T W R S I 39 T Q R R V R
5 A I Y R N Q 40 R Y T K S T
6 Y K I G G S 41 R R Y L D R
7 Q F K N V S 42 R R D R S L
8 P G V K A V 43 V K M R R D
9 W E H K S S 44 G T S R N K
10 A M Y R A V 45 G S L R S R
11 A S A R S I 46 H G K S R P
12 L M T K M G 47 M H V R R R
13 A V Y K A G 48 T K L R G R
14 V A R M Y K 49 R R V K Q T
15 F R P K V S 50 G V N K N K
16 F K K V R K 51 W T R R N G
17 L V W R S H 52 T Q R R L R
18 I V W K R Q 53 M F L A K R
19 W R Y S M R 54 K S K S R D
20 T K W R A V 55 K R S R N G
21 S G Y K R R 56 T D L K S K
22 S A K V F K 57 A H N K R L
23 R F K K G K 58 S K M R M G
24 K T F R K N A 59 R E H R V N
25 N K T Y R R 60 M R R K R V
26 G F R K N A 61 A K K S K L
27 Y K S R K Y 62 V A S R S K
28 I Y R S R S 63 D L S R L K
29 A N F R G K 64 I N R S R Q
30 E K F R K K 65 L K R R N L
31 Y K I G G S 66 K S K S R D
32 P Y R G K N 67 G Y K N S A
33 I Y K E R K 68 I R Y K G K
34 L T K K V A 69 K R S R S G
35 M R K V S L
Peptide sequences have been shifted to the left or right to align the clones to a consensus sequence. The amino- and carboxy-terminal residues
flanking these sequences are contributed by the phage constant regions and are GGAG and GGAGSS, respectively.
among the selected substrate phage clones. Consequently,
we performed digestions of all 69 substrate phage, utiliz-
ing a series of increasingly stringent conditions, and we
analyzed the resulting reaction products using a sensitive
dot-blot assay [7] (Figure 2). 
Under the most stringent conditions adopted in these
experiments, 13 of the 69 selected phage were particularly
labile plasmin substrates (Table 2). Eight of these highly
labile substrate hexamers contained an arginine residue at
P1, while five hexamers contained a P1 lysine residue,
again suggesting that plasmin shows little preference
between these two basic P1 residues. Eight of the thirteen
substrate clones contained either tyrosine (five clones) or
phenylalanine (three clones) at P2. These data provide
additional support for tyrosine or phenylalanine at P2 and
arginine or lysine at P1 as optimal subsite occupancy for
peptide substrates of plasmin. Plasmin does not appear to
possess stringent specificity at the P3 position of sub-
strates; arginine, valine, glycine, and threonine are all
present at the P3 position of two of the 13 clones. At the
P1′ position of peptide substrates, plasmin appears to
prefer arginine (three clones), lysine (three clones), or
serine (three clones). Glycine is found at the P1′ position
in two clones. Plasmin also shows clear preferences at the
P2′ position of substrates; eleven of the 13 highly labile
substrate hexamers contain arginine (five clones), lysine
(three clones) or glycine (three clones) at this position. On
the basis of analysis of the 13 most rapidly cleaved
hexamer substrates, therefore, optimal subsite occupancy
for plasmin substrates, from P3–P2′, appears to be (V, G,
T, R > X) (Y, F) (R, K) ⇓ (R, K, S > G) (R > K, G), where
X represents a variety of amino acids and the arrow repre-
sents the site of peptide-bond hydrolysis. 
Confirmation of specificity by kinetic analysis of peptide
substrates 
Six peptides containing amino acid sequences present in
the most labile substrate phage were chosen for kinetic
analysis. In all cases, the predicted site of peptide-bond
hydrolysis was confirmed by mass spectral analysis of reac-
tion products. Plasmin cleaved these peptides with 
catalytic efficiencies (kcat/Km) varying from 4100 M–1s–1 for
peptide 1, to 1.2(10)6 M–1s–1 for peptide 6 (Table 3). By
contrast to the ability of plasmin to efficiently cleave the
peptides identified using substrate phage display, plasmin
cleaved peptide 7 (modeled after the plasminogen activa-
tion sequence) very poorly, exhibiting a kcat/Km value for
this reaction of only 1.7 M–1s–1. Thus, there is a 710,000-
fold difference between the efficiency of cleavage of the
optimal substrate identified by substrate phage display
and the plasminogen activation sequence, even though
both substrates possess arginine as a P1 residue. 
The primary physiological inhibitor of plasmin is 
α2-antiplasmin [9], a serpin whose reactive center loop has
presumably evolved to match the substrate specificity of
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Figure 2
Dot-blot proteolytic analysis of control and substrate phage clones.
Phage from individual clones were prepared, digested with the
indicated concentrations of plasmin for 15 min at 37°C, spotted onto a
nitrocellulose filter, and detected as described in the Materials and
methods section. Loss of positive staining indicates cleavage in the
randomized hexamer region of the gene III fusion protein to remove the
antibody epitope. Phage fTC-BAD is a negative control phage whose
randomized hexamer region does not contain a basic residue. Phage
5-66, 5-16, 5-108, 5-96 and 5-11 are individual phage clones isolated
during the fifth round of selection. 
fTC-BAD
5–66
5-16
5-108
5-96
5-11
0(Plasmin) m g/ml 0.2 0.5 1 5
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Table 2
Alignment of selected clones showing the highest reactivity
towards plasmin as determined by monitoring cleavage of
intact phage by a dot-blot assay.
Clone
#  P5 P4 P3 P2 P1 P1′ P2′ P3′ P4′ P5
6 Y K I G G S
13 A V Y K A G
23 R F K K G K 
27 Y K S R K Y 
28 I Y R S R S 
29 A N F R G K 
30 E K F R K K
38 V L R K R A
39 T Q R R V R 
45 G S L R S R
47 M H V R R R
52 T Q R R L R 
68 I R Y K G K
Peptide sequences have been shifted to the left or right to align the
clones to a consensus sequence. The amino- and carboxy-terminal
residues flanking these sequences are contributed by the phage
constant regions and are GGAG and GGAGSS, respectively.
plasmin very well. Surprisingly, however, when we
assayed peptide substrate 8 (modeled after the reactive
site within α2-antiplasmin) we discovered that it was
cleaved less efficiently than all six of peptides (1–6) iden-
tified by substrate phage display. The observation that
peptide 6 is cleaved 600 times more efficiently than the
α2-antiplasmin-based peptide 8 indicates the impressive
ability of substrate phage technology to elucidate optimal
subsite occupancy for proteases that could not have been
predicted from examining the sequence of physiological
substrates or inhibitors. 
The 710,000-fold difference in the catalytic efficiency of
plasmin for hydrolysis of peptides 6 and 7 occurs despite
the fact that peptides 6 and 7 share the same P1 residue,
arginine. The specificity of plasmin, therefore, is governed
to an unexpectedly large extent by interactions beyond the
S1 specificity pocket. To evaluate the role of non-S1 inter-
actions in defining the specificity of plasmin, we systemati-
cally introduced the P4, P3, P2, P1′ and P2′ residues of
peptide 7 into 6 to create peptides 9–13. Each of these pep-
tides was a much better substrate for cleavage by plasmin
than peptide 7, indicating that no single interaction
accounts for the extremely inefficient cleavage of 7 by
plasmin. Furthermore, introduction into peptide 6 of a
serine residue at P4, proline at P3, glycine at P2, or valine at
P1′ and P2′ reduced kcat/Km by 240, 22, 43, 35 and 110-fold,
respectively, relative to cleavage of 6. The finding that
every alteration reduces catalysis suggests that inefficient
catalysis of peptide 7 is due to the combination of subopti-
mal interactions at each non-S1 subsite. 
Site-selective cleavage of an engineered protein by plasmin
Our results with peptide substrates strongly suggested that
interactions of the non-S1 subsites are critical for defining
the specificity of plasmin. The physiological substrates of
plasmin, however, are folded proteins rather than peptides.
Consequently, to gain insights into whether the prefer-
ences for substrate hydrolysis observed for peptide cleav-
age would also apply within the framework of a model
protein, we engineered the selected hexapeptide sequence
from substrate 6 into staphyloccocal nuclease (SNase) [24].
SNase is an ideal model protein substrate for investigating
proteolysis because it has been well characterized by exten-
sive structural and mutagenesis studies. SNase contains a
loop at residues 43–52 which is accessible to and preferen-
tially cleaved by trypsin and which can be mutated without
altering the structure of other regions of the protein. Cleav-
age of SNase within this surface loop yields two stable
products that remain associated noncovalently. The kinetic
constants for hydrolysis of SNase variants by trypsin family
proteases can therefore be calculated by measuring the
time-dependent appearance of the two cleavage products
using sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS–PAGE) and densitometry. 
We engineered four variants of SNase. One of these, 14,
contained the optimal P4–P2′ sequence for cleavage by
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Table 3
Comparison of kcat, Km, and kcat/Km for peptide hydrolysis by plasmin.
Substrate kcat Km kcat/Km
(Pn,...P3, P2, P1,↓P1′, P2′, P3′....Pn′)* (s–1) (µM) (M–1 s–1) Kcat/Km relative to 7
Plasmin-selective peptides from phage display screen
1 LGGSGTQR↓RLRLE 12 2900 4.1 (10)3 2400
2 LGGSGANFR↓GKLE 68 2400 2.8 (10)4 16,000
3 LGGSGYK↓IGGSLE 12 210 5.7 (10)4 34,000 
4 LGGSIRYK↓GKSLE 44 750 5.9 (10)4 35,000
5 LGGSGAVYK↓AGLE 40 420 9.5 (10)4 56,000
6 LGGSGIYR↓SRSLE 120 100 1.2 (10)6 710,000
Activation sequence from plasminogen†
7 KKSPGR↓VVGGSVAH 0.0086 5100 1.7 1
Reactive center sequence from α 2-antiplasmin
8 LGGSAMSR↓MSSLE 3.2 1600 2.0 (10)3 1200
Introduction of residues from peptide 7 into peptide 6
9 LGGSSIYR↓SRSLE 35 6800 5.1 (10)3 3000
10 LGGSGPYR↓SRSLE 92 1700 5.4 (10)4 31,000
11 LGGSGIGR↓SRSLE 53 1850 2.9 (10)4 17,000
12 LGGSGIYR↓VRSLE 16 470 3.4 (10)4 20,000
13 LGGSGIYR↓SVSLE 39 3700 1.1 (10)4 6500
*Positional nomenclature of subsite residues. Arrows denote the
position of peptide bond hydrolysis. The peptide bond is cleaved
between P1 and P1′. Residues in bold are those introduced from
peptide 7 into peptide 6. Standard errors calculated for these
measurements varied from 4–30%. †To prevent cyclization of this
peptide substrate, serine residues have been substituted for the
cysteine residues found in plasminogen at positions P4 and P5′.
plasmin, GIYRSR. Cleavage of this variant by plasmin was
characterized by a kcat/Km value of ~100 000 M–1s–1
(Table 4), a value similar to that previously observed for
cleavage of engineered SNase variants by trypsin [24]. Two
variants, 15 and 16, contained altered residues at P2 and P4
and were both less efficient substrates than 14. Especially
striking is the finding that introduction of a single methyl
group at the P4 position through a glycine to alanine muta-
tion reduces catalysis of engineered SNase variant 16 by
almost tenfold relative to 14. The preference for cleavage
of engineered SNase 14 relative to similar substrates 15 and
16 suggests that the selected sequence from phage display
that was used to create SNase 14 is an ideal sequence for
designing proteins to be targets for cleavage by plasmin. 
We also assayed a SNase variant (17) that contained the
hexapeptide sequence from the activation site of plas-
minogen. In contrast to efficient cleavage of substrate 14,
we could not detect any selective cleavage with the 43–52
loop of 17. As with peptide substrates, therefore, non-P1
subsite occupancy can dramatically modulate the speci-
ficity of plasmin toward protein substrates. 
Engineering plasminogen for activation by plasmin:
removing a constraint on protease cascades
The extremely low activity of plasmin towards peptides
containing the plasminogen activation cleavage-site
sequence suggested that plasmin would exhibit poor
autoactivation activity (i.e. be unable to convert plasmino-
gen into plasmin). To test this hypothesis, we examined
cleavage of microplasminogen [25,26], a readily expressed
variant of plasminogen, by catalytic amounts of plasmin.
We constructed variants of microplasminogen with the
active-site serine residue replaced by alanine so that any
plasmin formed during the reaction would be catalytically
inactive. This was an important consideration because if
active plasmin was formed, it would increase the concen-
tration of enzyme and prevent kinetic analysis of cleav-
age. As expected, we observed that the activity of
wild-type (wt) plasmin towards microplasminogen (micro-
plg) 18 containing the wt activation sequence was low.
The kcat/Km value measured for this autoactivation reac-
tion was ~340 M–1s–1 (Table 5).
The plasminogen cleavage site is located within a nine-
residue, disulfide-bonded surface loop in native plasmino-
gen, and constraints imposed upon the conformation of the
cleavage sequence by this location might contribute to the
poor autoactivation activity of plasmin. To investigate this
possibility, we constructed a variant of micro-plg in which
these two cysteine residues (at positions 558 and 566 in
the plasminogen numbering system) had been replaced by
serine residues. This variant, micro-plg 19, also carried the
Ser741→Ala mutation to facilitate kinetic analysis of its
activation by wt plasmin. The catalytic efficiency of
plasmin toward micro-plg 19 was ~1.1 × 103 M–1s–1, which
is only about threefold higher than the enzyme’s activity
toward wt micro-plg. Any constraints imposed by the
Cys558–Cys566 disulfide bond, therefore, have little influ-
ence on the autoactivation reaction.
The kinetic analysis of the activation of micro-plgs 18 and
19 described above indicated that the wt plasminogen acti-
vation cleavage sequence, whether present in the zymogen
in a cyclic (micro-plg 18) or ‘linear’ configuration (micro-
plg 19), is a poor substrate for plasmin. We therefore con-
structed two additional variants of micro-plg to test the
hypothesis that specific subsite occupancy that enhanced
the lability of peptide substrates toward plasmin could also
enhance the lability of plasminogen toward plasmin. In the
variant micro-plg 20, the P3, P2, P1′, and P2′ residues of
the cyclic activation site of micro-plg 18 are replaced with
the corresponding residues present in the most labile,
selected peptide (6). By contrast to wt micro-plg, this new
micro-plg variant was efficiently cleaved by plasmin, with a
kcat/Km value of ~6.8 × 105 M–1s–1, increasing the ‘autoacti-
vation activity’ of plasmin by a factor of ~2000. Similar
results were obtained with micro-plg variants containing
the activation sequence in a linear configuration. Micro-plg
21, which contains the optimal P4–P2′ sequence identified
by substrate phage display, was cleaved by plasmin with a
catalytic efficiency of ~7.1 × 105 M–1s–1. 
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Table 4
Kinetic parameters kcat, Km, and kcat/Km for the hydrolysis by plasmin of SNase variants containing various target sequences.
Substrate kcat Km kcat /Km Kcat/Km
(P4,P3, P2, P1,↓P1′, P2′,)* s–1 (µM) (M–1 s–1) relative to 14
14 GIYR↓SR 0.6 5.8 1 (10)5 1
15 GIVR↓SR 0.039 12 3.3 (10)3 0.03
16 AIYR↓SR 0.036 3 1.2 (10)4 0.12
17 SPGR↓VV nd nd nd –
*Positional nomenclature of subsite residues. Arrows denote the position of peptide-bond hydrolysis. The peptide bond is cleaved between P1 and
P1′. Residues in bold are altered from parent selected sequence 14. nd, no selective cleavage detected. Standard errors calculated for these
measurements varied from 4–30%.
Interplay of substrate specificity and in vivo physiology for
plasmin
This study reveals that the sequence (V, G, T, R > X) (Y,
F) (R, K) ⇓ (R, S, K > G) (R > K, G) (where X indicates a
variety of amino acids) represents optimal subsite occu-
pancy, from P3–P2′, for peptide substrates of plasmin.
Optimal subsite occupancy is similar for peptide and
protein substrates of plasmin. The substrate specificity of
plasmin is both less stringent and significantly different
than that of the most closely related homologs, the plas-
minogen activators t-PA and u-PA. This divergence is
most obvious at the P2 position, where plasmin strongly
prefers tyrosine or phenylalanine and t-PA and u-PA
strongly prefer glycine or alanine. The structural basis of
this distinction is almost certainly the six-residue deletion,
compared with trypsin and chymotrypsin, within the 90-
loop of plasmin. This deletion, which eliminates the con-
served ‘99-β-hairpin’ present in most (chymo)trypsin-like
proteases and creates the ‘94-shunt’, substantially opens
and enlarges the P2 pocket of plasmin compared with 
t-PA or u-PA [27,28] (Figure 3). This deletion also exposes
the catalytic triad to solvent, which would be expected to
significantly weaken the hydrogen-bonding network
formed by these three residues and therefore markedly
reduce catalysis by decreasing the nucleophilicity of the
active-site serine. Proper placement of a large P2 residue
in the plasmin–substrate complex, however, could elimi-
nate this barrier to efficient catalysis by shielding the
plasmin catalytic triad from solvent.
Textbook models of serine protease specificity often
emphasize the role of the S1, or ‘primary’, specificity pocket
in determining substrate specificity. Our data for plasmin,
however, reveal that occupancy of the surrounding non-S1
subsites can modulate the activity of plasmin towards
peptide substrates by approximately six orders of magni-
tude, making them critical determinants for substrate selec-
tivity. This property of plasmin is surprising. Like trypsin,
plasmin is a very active protease, and the specificity of
highly active, trypsin-like enzymes has been generally con-
sidered to be dictated predominantly by the P1 residue. 
Negative selectivity: a mechanism to avoid short-circuiting
regulation of protease cascades
This extreme dependence on non-P1 subsite occupancy
for efficient catalysis is physiologically important because
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Table 5
Kinetic parameters kcat, Km and kcat/Km for the hydrolysis by plasmin of microplasminogen variants containing various target
sequences.
Substrate kcat Km kcat /Km Kcat/Km
(P4, P3, P2, P1,↓P1′, P2′,)* s–1 (µM) (M–1 s–1) relative to 18
18 CPGR↓VV 0.0016 4.7 3.4(10)2 1.0
19 SPGR↓VV† 0.039 36.0 1.1(10)3 3.2
20 CIYR↓SR 2.7 4.0 6.8(10)5 2000
21 GIYR↓SR† 1.5 2.0 7.1(10)5 2100
*Positional nomenclature of subsite residues. Arrows denote the position of peptide-bond hydrolysis. The peptide bond is cleaved between P1 and
P1′. †P5′ (not shown) is mutated from cysteine to serine. In all four substrates, the catalytic serine (Ser741) has been mutated to alanine. Residues in
bold are altered from wt plasminogen sequence 18. Standard errors calculated for these measurements varied from 4% to 30%.
Figure 3
View of the active site region of (a) plasmin
[28] and (b) t-PA [31]. Residues forming the
catalytic triad (Asp102, His57 and Ser195)
are colored red. Small-molecule inhibitors
[Glu–Gly—Arg–chloromethyl ketone for
plasmin and 2,7-bis-(4-amidinobenzylidene)-
cycloheptan-1-one for t-PA] are shown in
green. The additional six residues in the 
90-loop of t-PA, compared with plasmin, are
shown in orange. The shorter 90-loop in
plasmin exposes the catalytic triad to solvent
and substantially enlarges the S2 pocket. 
it accounts for the poor recognition of the plasminogen
cleavage site by plasmin. Presumably, this poor recogni-
tion occurs because plasmin has been subjected to a very
strong, negative selection against autoactivation activity
during its evolution from a trypsin-like progenitor. This
stringent negative selection might have driven both the
development of a catalytic machinery that is extraordinar-
ily responsive to suboptimal non-P1 subsite occupancy,
and the creation of an activation cleavage sequence in the
zymogen plasminogen that contains suboptimal non-P1
subsite occupancy for the mature enzyme plasmin. Strong
negative selection against autoactivation activity might be
especially critical for proteases such as plasmin that partic-
ipate in proteolytic cascades. 
As all three proteases that participate in the fibrinolytic
system, t-PA, u-PA and plasmin, recognize the basic
residues arginine or lysine at P1, the creation of an activa-
tion cleavage sequence in plasminogen that contained a
nonbasic P1 residue would prevent not only autoactivation
of plasmin(ogen) but also the activation of plasminogen by
the physiological plasminogen activators t-PA and u-PA.
Consequently, the evolution of plasmin(ogen) to utilize
exclusively suboptimal non-P1 subsite occupancy to
prevent autoactivation, and therefore maintain a basic P1
residue in the activation cleavage site, appears to have
played an important role in preserving the integrity of the
fibrinolytic system. 
Strong selection against cleavage of a particular sequence
(i.e. negative selection) contrasts sharply with the positive
selection that normally creates the restricted substrate
specificity of enzymes (Figure 4). In most cases, evolution
leads to optimal catalysis of a specific substrate relative to
chemically related molecules. For plasmin, however, the
opposite has been true. The evolution of specificity has
been driven by the necessity not to cleave the plasmino-
gen activation sequence while retaining high activity
against many other substrates. It would not be surprising if
particular enzymes that participate in other proteolytic
cascades had been subjected to similar selective pressures. 
These observations might also provide additional insight
into the evolution of substrate specificity by t-PA and 
u-PA. Like plasmin, t-PA and u-PA exhibit poor activity
towards peptides containing the plasminogen activation
cleavage-site sequence. This low activity appeared para-
doxical because the plasminogen cleavage site is the phys-
iological target sequence for t-PA and u-PA. Moreover, we
used substrate phage display to isolate peptides that were
efficiently cleaved by both t-PA and u-PA, which elimi-
nated the possibility that this low activity against plas-
minogen-derived peptides was due to an intrinsic low
activity towards peptides. Based on the current study and
the high homology between t-PA, u-PA and plasmin, we
speculate that the poor activity of t-PA and u-PA towards
plasminogen-derived peptides might reflect the strong
negative selection against cleavage of this sequence by
plasmin. Consequently, the development of high activity
towards plasminogen by t-PA and u-PA has relied on the
evolution of productive, secondary enzyme–substrate
interactions and/or the participation of macromolecular co-
factor(s) to overcome suboptimal interactions surrounding
the scissile bond.
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Figure 4
Positive-versus-negative selectivity.
(a) Proteases that exhibit positive selectivity
for substrate cleave a target protein while
leaving other proteins intact. (b) Plasmin,
which exhibits negative selectivity, cleaves a
wide range of proteins but leaves
plasminogen intact.
(a)                            Positive selectivity: catalysis of one substrate,
                                                related molecules untouched
(b)                             Negative selectivity: catalysis of many substrates,
                                                   one related molecule untouched
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Significance
Identification of the genes that constitute the human
genome will almost certainly lead to a greater under-
standing of biological processes as interdependent
systems. A prerequisite for this understanding is appreci-
ation of the sophisticated regulatory mechanisms that
control enzyme activities. One effective strategy of
enzyme regulation that is frequently encountered in
complex biological systems is the use of protease cascades
for efficient signal transduction. In this study, we investi-
gated how the human fibrinolytic cascade balances the
competing demands of stringent specificity and highly effi-
cient proteolysis. 
We used substrate phage display to define the optimal
selectivity of plasmin at subsites P3 to P2′ to be (V, G,
T, R > X) (Y, F) (R, K) ⇓ (R, S > K, G) (R, K, G) for
cleavage of peptide substrates. Knowledge of these pref-
erences will facilitate the design of selective inhibitors of
plasmin and might aid prediction of plasmin-sensitive
sites within potential physiological substrates. These
data also demonstrate that the substrate specificity of
plasmin is strikingly different from that of tissue-type
plasminogen activator (t-PA) and urokinase-type plas-
minogen activator (u-PA), the other two serine pro-
teases that participate in the fibrinolytic cascade, clearly
reflecting the distinct biological roles of these enzymes. 
An important finding of this study is that plasmin
cleaves an optimized substrate 710,000-fold more effi-
ciently than a substrate containing the sequence that is
cleaved to convert plasminogen into plasmin. This
710,000-fold difference in catalytic activity is achieved
even though both target sequences contain the same P1
residue (i.e. arginine), demonstrating that the substrate
specificity of plasmin exhibits an unexpectedly large
dependence upon interactions at non-S1 subsites. We
conclude that plasmin has evolved to be a highly active
protease that uses non-S1 interactions to discriminate
stringently against cleavage of its own activation
sequence. This ‘negative selectivity’ against autoactiva-
tion prevents  short-circuiting of the fibrinolytic cascade
and might represent a general strategy for maintaining
the integrity of protease cascades in complex biological
systems. 
Materials and methods
Reagents
Competent MC1061 (F–) Escherichia coli and nitrocellulose were pur-
chased from Bio-Rad Laboratories, (Hercules, CA). Pansorbin 
(Protein A-bearing Staphyloccus aureus) cells were obtained from Cal-
biochem (San Diego, CA). K91 (F+) and MC1061 (F–) strains of E. coli
were provided by Steve Cwirla (Affymax, Santa Clara, CA). MAb 3-E7
was purchased from Gramsch Laboratories (Schwabhausen,
Germany). Plasmin was purchased from American Diagnostica (Green-
wich, CT, USA). The substrate phage library fTC-LIB-N6 was gener-
ously provided by Marc Navre (Affymax).
Substrate phage display 
We and others have previously described protocols for panning poly
valent substrate phage [6,7,21,22]. For plasmin, selection of substrate
phage was performed as follows: ~2 × 1010 phage (fTC-LIB-N6 library)
were digested in a plasmin-compatible assay buffer (50 mM Tris-HCl
(pH 7.4),100 mM NaCl, 1 mM EDTA, 0.01% Tween 20) for between
30 min and 2 h at 37°C using 1–5 µg/ml of plasmin. The total volume
of each digest was 250 µl. Digestion of the phage by plasmin was ter-
minated by the addition of 20 µg/ml of aprotinin. Reaction mixtures
were then placed on ice, bovine serum albumin (0.1%) and mAb 3-E7
(10 µg) were added, and incubation was continued for 30 min. Follow-
ing addition of 100 µl of pansorbin cells, the reaction mixtures were
rocked at 4°C for 1 h. Samples were centrifuged for 2 min, the super-
natants were recovered and the pansorbin adsorption was repeated. A
small aliquot of the phage present in the final supernatant was used for
titering, and the remaining phage were amplified overnight in K91 cells.
Individual clones were selected from the titer plates and grown
overnight in 2 ml LB media for dot-blot analysis.
Dot-blot assay 
Phage were precipitated from 100 µl of culture supernatant by adding
20 µl of 20% polyethylene glycol, 2.5 M NaCl, incubating the mixture
for 30 min on ice, and spinning the mixture for 5 min in a microcen-
trifuge. The resulting phage pellets were resuspended in 10 µl of TBS
(50 mM Tris-HCl (pH 7.4), 150 mM NaCl) and transferred into individ-
ual wells of a 96-well microtiter plate. 90 µl of buffer containing varying
concentrations of plasmin was then added to each well and the plate
was incubated between 15 min and 2 h at 37°C. Following this incuba-
tion, 50 µl of the reaction mixture was added to 50 µl of TBS buffer
containing 20 µg/ml of aprotinin. These samples were spotted onto a
nitrocellulose filter using a dot-blot apparatus (BioRad). The nitrocellu-
lose filter was blocked with 7% nonfat milk in TBS-T (TBS + 0.05%
Tween 20) for 1 h, washed three times with TBS-T, incubated for 1 h
with mAb 3-E7 at 1 µg/ml, washed several times, and incubated 1 h
with a 1:5000 dilution of a goat anti-mouse IgG horseradish peroxidase
conjugate (Amersham Pharmacia Biotech AB, Uppsala, Sweden).
Finally, the filter was washed several times with TBS-T and stained
using the Amersham Western Enhanced Chemiluminescent kit. 
Kinetics of peptide cleavage
Peptides were synthesized and purified as described [6,7]. Kinetic data
were obtained by incubating varying concentrations of peptide with a
constant enzyme concentration to achieve between 5% and 20%
cleavage of peptide during each reaction. Reactions were performed in
50 mM Tris, pH 8.0, 10 mM CaCl2, 0.1% Tween-20, as described pre-
viously [6,7]. The percentage of cleavage was correlated with the time
of digestion to ensure that conditions were within the range of linear
responsiveness for the assay. Both parent peptides and cleavage prod-
ucts were collected and characterized by mass spectral analysis using
a Voyager MALDI–TOF spectrometer (PerSeptive Biosystems, Foster
City, CA). Data were interpreted by Eadie–Hofstee analysis.
Kinetics of Staphylococcal nuclease cleavage 
Potential protein substrates were incubated with plasmin for various
time periods at 37°C. Substrate protein concentrations varied from
1–20 µM. For kinetic assays, plasmin concentrations were 50 nM, and
five to nine substrate concentrations were used within the range listed
above. Proteolytic digests were terminated between 10% and 20%
completion by addition of loading buffer and heating to 100°C for
10–20 min. Samples of each digest were separated on 15% SDS-
polyacrylamide gels and stained with Coomassie brilliant blue. After
destaining, substrate to proteolytic product ratios were determined by
densitometric scanning on a model 300A scanning densitometer (Mol-
ecular Dynamics, Sunnyvale, CA, USA) operating with Image Quant
3.0 software. The ratios obtained were used to determine initial veloci-
ties of cleavage. The site of cleavage was confirmed by amino-terminal
amino acid sequencing of the carboxyl-terminal proteolytic product.
Values for Vmax and Km were derived from Eadie–Hofstee analysis.
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Expression and purification of recombinant plasminogen 
Pichia pastoris strain SMD1168 and the expression plasmid pPic9KX
(pPic9K with an XhoI site in the kanamycin-resistance gene deleted by
silent mutagenesis) were generously supplied by Elizabeth Komives
(University of California, San Diego, CA). A truncated form of the plas-
minogen cDNA encoding residues 546–791 which contain only the
protease domain and enough of the activation peptide to allow forma-
tion of the interdomain C548–C666 disulfide bond was fused directly
to coding sequence for an amino-terminal six-residue histidine tag by
polymerase chain reaction (PCR) amplification. This construct was then
ligated into the XhoI and NotI unique restriction sites in the polylinker of
vector pPic9KX so that the histidine tag is directly downstream of, and
in frame with, the AAAAGA sequence that terminates the coding region
for the matα leader sequence responsible for secretion of each fusion
protein, and encodes a KEX2 protease cleavage site. 
Mutants were constructed by the PCR gene splicing by overlap exten-
sion (SOE) technique [29] using this vector as template. These plas-
mids were then linearized at SacI or BglII restriction sites and
transformed into P. pastoris by electroporation [30]. Expressing clones
were screened for by batching 0.5 ml induced media onto 20 µl Ni2+
resin, eluting in 0.5 M Imidazole, 50 mM sodium acetate, pH 7.5,
50 mM NaCl and running eluents on 10% polyacrylamide gels. Pro-
teins were expressed by growing each expressing clone in 1l of
BMGY media (1.0% yeast extract, 2.0% peptone, 100 mM potassium
phosphate buffer pH 6.0, 2% glycerol, 3.4 g yeast nitrogen base, 10 g
(NH4)2SO4, and 0.4 µg/ml biotin) for 48 h, starting with a fresh 20 ml
inoculum grown in 1% yeast extract, 2% peptone, 2% D-glucose
(YPD) for 24 h. Cultures were induced by spinning down cells 10 min
at 3000 rpm, discarding spent BMGY and resuspending cells in
200 ml of BMMY (as BMGY, except that 2% glycerol is replaced with
0.5% methanol). After 24 h in BMMY, cultures were harvested and
plasminogens were purified using Ni2+ affinity chromatography. Puri-
fied protein was aliquotted and stored at –80°C. Protein stock con-
centrations were determined by BCA assay using a kit supplied by
Pierce (Rockford, IL).
Kinetics of plasminogen activation 
Concentrations of each plasminogen variant ranging from 1 µM to
35 µM were assayed kinetically for rates of activation by 1 nM to
100 nM plasmin. Because each of the mutants assayed lacks its cat-
alytic serine residue, its cleavage by wt plasmin was monitored by
densitometric scanning of substrate and product bands in Coom-
massie-stained polyacrylamide gels. Quantitation of band density was
accomplished using the shareware program NIH Image 1.61. Veloci-
ties were determined from the percentages of cleavage in each reac-
tion. Kinetic constants were obtained from Eadie-Hofstee plots.
Values reported are an average of two to three assays.
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